Myomo, Inc.
General ticker "MYO" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $133.3M (TTM average)
Myomo, Inc. does not follow the US Stock Market performance with the rate: -26.4%.
Estimated limits based on current volatility of 3.6%: low 0.91$, high 0.98$
Factors to consider:
- Total employees count: 184 (+73.6%) as of 2024
- US accounted for 0.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Reimbursement risks, Operational and conduct risks, Geopolitical risks, Strategic risks and growth management, Regulatory and compliance
- Current price 44.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.64$, 6.56$]
- 2025-12-31 to 2026-12-31 estimated range: [1.74$, 4.50$]
Financial Metrics affecting the MYO estimates:
- Positive: with PPE of -36.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.41 <= 0.04
- Positive: Investing cash flow per share per price, % of 0.11 > -0.62
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
- Positive: 42.53 < Shareholder equity ratio, % of 58.50 <= 64.17
Short-term MYO quotes
Long-term MYO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.56MM | $19.24MM | $32.55MM |
| Operating Expenses | $26.23MM | $27.47MM | $38.76MM |
| Operating Income | $-10.67MM | $-8.23MM | $-6.21MM |
| Non-Operating Income | $0.02MM | $0.24MM | $0.39MM |
| R&D Expense | $2.48MM | $2.64MM | $4.77MM |
| Income(Loss) | $-10.65MM | $-7.99MM | $-5.82MM |
| Taxes | $0.07MM | $0.16MM | $0.37MM |
| Profit(Loss)* | $-10.72MM | $-8.15MM | $-6.18MM |
| Stockholders Equity | $6.36MM | $8.99MM | $24.71MM |
| Inventory | $1.40MM | $1.80MM | $3.17MM |
| Assets | $10.16MM | $14.58MM | $42.24MM |
| Operating Cash Flow | $-10.23MM | $-6.17MM | $-3.29MM |
| Capital expenditure | $0.11MM | $0.15MM | $1.36MM |
| Investing Cash Flow | $-0.31MM | $-2.03MM | $0.26MM |
| Financing Cash Flow | $0.38MM | $9.71MM | $20.93MM |
| Earnings Per Share** | $-1.52 | $-0.28 | $-0.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.